Unimark Remedies Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is SOLIFENACIN SUCCINATE, with a corresponding US DMF Number 23965.
Remarkably, this DMF maintains an Active status since its submission on July 28, 2010, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 07, 2014, and payment made on March 21, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II